Sanofi moved ahead with a plan to sell a controlling stake in its consumer-healthcare unit Opella to Clayton Dubilier & Rice, entering exclusive talks for a deal that values the business at $17.4 billion, including debt.
Sanofi Enters Exclusive Talks With CD&R Over Consumer Business Stake Sale
